🇺🇸 FDA
Patent

US 9216983

Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

granted A61PA61P33/06

Quick answer

US patent 9216983 (Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity) held by The Board of Regents of the University of Texas System expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P33/06